Terms: = Germ cell tumor AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS
336 results:
1. Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.
Tazhibi M; McQuillan N; Wei HJ; Gallitto M; Bendau E; Webster Carrion A; Berg X; Kokossis D; Zhang X; Zhang Z; Jan CI; Mintz A; Gartrell RD; Syed HR; Fonseca A; Pavisic J; Szalontay L; Konofagou EE; Zacharoulis S; Wu CC
J Transl Med; 2024 Mar; 22(1):320. PubMed ID: 38555449
[TBL] [Abstract] [Full Text] [Related]
2. Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression.
Nakamura M; Yoshimitsu M; Magara T; Kano S; Kato H; Morita A
Exp Dermatol; 2024 Mar; 33(3):e15062. PubMed ID: 38532566
[TBL] [Abstract] [Full Text] [Related]
3. Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?
Padonou F; Vanhulst T; Langouo-Fontsa MD
Curr Opin Oncol; 2024 Mar; 36(2):63-68. PubMed ID: 38441065
[TBL] [Abstract] [Full Text] [Related]
4. Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma.
Cheng X; An J; Lou J; Gu Q; Ding W; Droby GN; Wang Y; Wang C; Gao Y; Anand JR; Shelton A; Satterlee AB; Mann B; Hsiao YC; Liu CW; Lu K; Hingtgen S; Wang J; Liu Z; Miller CR; Wu D; Vaziri C; Yang Y
Nat Commun; 2024 Mar; 15(1):1957. PubMed ID: 38438348
[TBL] [Abstract] [Full Text] [Related]
5. PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanoma.
Roy A; Chakraborty AR; DePamphilis ML
Mol Oncol; 2024 Apr; 18(4):988-1011. PubMed ID: 38414326
[TBL] [Abstract] [Full Text] [Related]
6. Effects of immunogenic cell death-inducing chemotherapeutics on the immune cell activation and tertiary lymphoid structure formation in melanoma.
Zhao H; Zhao Y; Zhang S; Wang Z; Yu W; Dong N; Yang X; Zhang X; Sun Q; Hao X; Ren X
Front Immunol; 2024; 15():1302751. PubMed ID: 38384466
[TBL] [Abstract] [Full Text] [Related]
7. Immunotherapy for non-small cell lung cancer.
Kagamu H
Respir Investig; 2024 Mar; 62(2):307-312. PubMed ID: 38310751
[TBL] [Abstract] [Full Text] [Related]
8. Profiling of Unfolded Protein Response Markers and Effect of IRE1α-specific Inhibitor in Pituitary Neuroendocrine tumor.
Morita S; Uraki S; Ariyasu H; Tsuji T; Doi A; Furuta H; Yamoto T; Nakao N; Akamizu T; Matsuoka TA
Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38289718
[TBL] [Abstract] [Full Text] [Related]
9. The molecular subtypes and clinical prognosis characteristic of tertiary lymphoid structures-related gene of cutaneous melanoma.
Li J; Chen G; Luo Y; Xu J; He J
Sci Rep; 2023 Dec; 13(1):23097. PubMed ID: 38155221
[TBL] [Abstract] [Full Text] [Related]
10. Pathologic changes in neuronal intranuclear inclusion disease are linked to aberrant fus interaction under hyperosmotic stress.
Wang H; Zheng Y; Yu J; Meng L; Zhang W; Hong D; Wang Z; Yuan Y; Deng J
Neurobiol Dis; 2024 Jan; 190():106391. PubMed ID: 38145851
[TBL] [Abstract] [Full Text] [Related]
11. Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
Chen KT; Huang CY; Pai PC; Yang WC; Tseng CK; Tsai HC; Li JC; Chuang CC; Hsu PW; Lee CC; Toh CH; Liu HL; Wei KC
J Neurooncol; 2023 Dec; 165(3):535-545. PubMed ID: 38060066
[TBL] [Abstract] [Full Text] [Related]
12. Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening.
Martinez PJ; Green AL; Borden MA
J Control Release; 2024 Jan; 365():412-421. PubMed ID: 38000663
[TBL] [Abstract] [Full Text] [Related]
13. Focused ultrasound for brain metastases: an update on global clinical trials.
Chen YH; Moore D; Lee CC; Su YH
J Neurooncol; 2023 Oct; 165(1):53-62. PubMed ID: 37910281
[TBL] [Abstract] [Full Text] [Related]
14. Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics.
Griñán-Ferré C; Jarné-Ferrer J; Bellver-Sanchís A; Codony S; Puigoriol-Illamola D; Sanfeliu C; Oh Y; Lee S; Vázquez S; Pallàs M
CNS Neurosci Ther; 2024 Apr; 30(4):e14511. PubMed ID: 37905690
[TBL] [Abstract] [Full Text] [Related]
15. Correlation of Neuroendocrine Differentiation with a Distinctively Suppressive Immune Microenvironment in Gastric Cancer.
Zou Y; Li D; Yu X; Zhou C; Zhu C; Yuan Y
Neuroendocrinology; 2024; 114(2):192-206. PubMed ID: 37827134
[TBL] [Abstract] [Full Text] [Related]
16. tumor lysis syndrome in premature infant prompting early resection of a large sacrococcygeal teratoma: a case report.
Dey A; Wyrebek R; Torres L; Escoto D; Shakeel F; Mayer J
BMC Pediatr; 2023 Sep; 23(1):440. PubMed ID: 37660010
[TBL] [Abstract] [Full Text] [Related]
17. Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma.
Zhan Y; Song Y; Qiao W; Sun L; Wang X; Yi B; Yang X; Ji L; Su P; Zhao W; Liu Z; Ren W
Br J Cancer; 2023 Oct; 129(7):1083-1094. PubMed ID: 37580442
[TBL] [Abstract] [Full Text] [Related]
18. Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.
Rosenberg MI; Greenstein E; Buchkovich M; Peres A; Santoni-Rugiu E; Yang L; Mikl M; Vaksman Z; Gibbs DL; Reshef D; Salovin A; Irwin MS; Naranjo A; Ulitsky I; de Alarcon PA; Matthay KK; Weigman V; Yaari G; Panzer JA; Friedman N; Maris JM
Cell Rep; 2023 Aug; 42(8):112879. PubMed ID: 37537844
[TBL] [Abstract] [Full Text] [Related]
19. Adamantinoma-like Ewing Sarcoma (ALES) May Harbor fus Rearrangements : A Potential Diagnostic Pitfall.
Palsgrove DN; Foss RD; Yu W; Garcia J; Rooper LM; Rekhtman N; Antonescu C; Gagan J; Agaimy A; Bishop JA
Am J Surg Pathol; 2023 Nov; 47(11):1243-1251. PubMed ID: 37494548
[TBL] [Abstract] [Full Text] [Related]
20. Local immunotherapy of glioblastoma: A comprehensive review of the concept.
Sabahi M; Salehipour A; Bazl MSY; Rezaei N; Mansouri A; Borghei-Razavi H
J Neuroimmunol; 2023 Aug; 381():578146. PubMed ID: 37451079
[TBL] [Abstract] [Full Text] [Related]
[Next]